Deborah Penza
Plus aucun poste en cours
Profil
Actuellement, Deborah Collins Penza occupe le poste de Chief Compliance Officer chez Hikma Pharmaceuticals Plc. Auparavant, elle a été vice-présidente chez Strategic Management Systems, chef de la conformité et vice-présidente principale chez Impax Laboratories LLC, chef de la conformité chez Actavis, Inc. et vice-présidente de la conformité chez Elan Corp. Plc. Elle a obtenu un diplôme d'études supérieures de la George Mason University School of Law, un diplôme d'études supérieures de la George Washington University et un diplôme de premier cycle de la Florida Atlantic University.
Anciens postes connus de Deborah Penza
| Sociétés | Poste | Fin |
|---|---|---|
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Compliance Officer | 01/08/2018 |
| HIKMA PHARMACEUTICALS PLC | Compliance Officer | - |
Strategic Management Systems
 Strategic Management Systems Packaged SoftwareTechnology Services Strategic Management Systems develops organizational performance software products for businesses. The private company is based in Philadelphia, PA and has subsidiaries in the United States. The CEO of the company is Richard Kusserow. | Corporate Officer/Principal | - |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Compliance Officer | - |
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Compliance Officer | - |
Formation de Deborah Penza
| George Washington University | Graduate Degree |
| Florida Atlantic University | Undergraduate Degree |
| George Mason University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HIKMA PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 4 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Health Technology |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Health Technology |
Strategic Management Systems
Strategic Management Systems Packaged SoftwareTechnology Services Strategic Management Systems develops organizational performance software products for businesses. The private company is based in Philadelphia, PA and has subsidiaries in the United States. The CEO of the company is Richard Kusserow. | Technology Services |
